Patent: 6,861,243
✉ Email this page to a colleague
Summary for Patent: 6,861,243
Title: | Genes containing a DNA sequence coding for hydroxynitrile lyase, recombinant proteins derived therefrom and having hydroxynitrile lyase activity, and use thereof |
Abstract: | New genes containing a DNA sequence coding for hydroxynitrile lyase, which genes can be prepared via a primer combination based on the DNA sequence of the 5\'-region of the mdl genes from Prunus serotina and from Prunus amygdalus and/or a primer 2 based on the 3\'-region of the DNA sequences of one of the hydroxynitrile lyase isoenzymes from Prunus serotina or from Prunus amygdalus, subsequent amplification with a DNA polymerase using a DNA from organisms, containing genes coding for hydroxynitrile lyase, as templates and cloning, and also recombinant proteins which can be prepared in suitable host cells by heterologous expression of the DNA sequence of said HNL genes, and proteins and fusion proteins derived therefrom and use of said proteins for preparing (R)- or (S)-cyanohydrins. |
Inventor(s): | Schwab; Helmut (Graz, AT), Glieder; Anton (Gleisdorf, AT), Kratky; Christoph (Graz, AT), Dreveny; Ingrid (Graz, AT), Pochlauer; Peter (Linz, AT), Skranc; Wolfgang (Vienna, AT), Mayrhofer; Herbert (Engerwitzdorf, AT), Wirth; Irma (Enns, AT), Neuhofer; Rudolf (Engerwitzdorf, AT), Bona; Rodolfo (Graz, AT) |
Assignee: | DSM Fine Chemicals Austria NFG GmbH & Co. KG (Linz, AT) |
Application Number: | 10/046,232 |
Patent Claims: | see list of patent claims |
Details for Patent 6,861,243
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | ⤷ Try a Trial | 2021-01-16 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Try a Trial | 2021-01-16 | |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | ⤷ Try a Trial | 2021-01-16 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |